The company offers drugs for cancer care and neurological diseases control. About evgen pharma plc evgen pharma is a clinical stage company developing sulforaphane based medicines for the treatment of multiple diseases the companys core technology is sulforadex, a method for synthesising and stabilising the naturally occurring compound sulforaphane and novel proprietary analogues based on sulforaphane. Our evgen pharma plc consensus estimates page is based on consensus analyst forecast, covering public companies earnings per share and revenue. View todays stock price, news and analysis for evgen pharma plc evg. Welcome to evgen pharma plc evgen pharma is a clinical stage drug development company developing sulforaphanebased medicines for the treatment of multiple diseases. The company operates through the segment of development of pharmaceutical products all within the united kingdom. Evg, a clinical stage drug development company focused on the treatment of cancer and neurological conditions, provides the following clarification. Evgen is a clinical stage drug development company focussed on the development of sulforaphanebased compounds, a new class of pharmaceuticals which are synthesised in a proprietary, welltolerated, stable formulation.
Evgen pharma poised for a pivotal year directorstalk. Evgen pharma evgen and the university of rochester school of medicine and dentistry have entered into a memorandum of understanding to advance sfx01 towards a clinical trial in chronic kidney disease ckd. Evgen pharma plc operates in the commercial physical research sector. Evg, the clinical stage drug development company developing sulforaphane based medicines for the treatment of multiple diseases, announces its unaudited interim results for the six months ended 30 september 2019. Stephen franklin chief executive evgen pharma plc linkedin. Stephen founded evgen pharma in 2007 and has over 20 years experience in the life science industries, focusing on the commercialisation of new technology. Apr 09, 2020 broker forecast northland capital issues a broker note on evgen pharma plc. Nov 17, 2016 evgen pharma plc is a clinical stage drug development company that is engaged in the development of programs that focuses on breast cancer and subarachnoid haemorrhage. Evgen pharma was founded in 2007 by dr stephen franklin in collaboration with two venture capital investors, enterprise ventures and imprimatur capital, with the objective of securing intellectual property rights relating to natural products with potential in healthcare. Evgen pharma is part of the medicine and biotech research sector.
Evgen pharma plc evgen pharma plc provides clinical stage drug development services. Evgen pharma plc, a clinical stage drug development company, focuses on the treatment of cancer and neurological diseases. Savvy investors should always reassess the situation of lossmaking companies frequently, and keep informed about whether or not these businesses are in a strong cash position. Evgen pharma plc evgen pharma or the company initiation of stem compassionate use programme and clinical trials update.
Evgen pharma plc university of rochester collaboration. Regulatory news articles for evgen pharma plc ord 0. Evg chief executive officer dr stephen franklin caught up with directorstalk for an exclusive interview to discuss the interim update on their stem clinical trial. Evgen pharma plc saw its shares jump almost 12% higher this morning after the drug development company reported positive updates on two phase ii clinical trials for its sfx01 treatment with no. Latest company news for evgen pharma stock market wire. Stock evgen pharma stock price today markets insider. This is the main evgen pharma plc stock chart and current price. Evgen pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evgen pharma plc is an active company incorporated on 2 october 2014 with the registered office located in liverpool, merseyside. Evgen pharma plc overview free company information from. Evgen pharma plc compassionate use programme and trials update. There are currently 6 active directors and 1 active secretary according to the latest confirmation statement submitted on 16th october 2019. Evgen is a clinical stage drug development company focussed on the development of sulforaphanebased compounds, a new class of pharmaceuticals which are synthesised in a proprietary, well. Lse share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
E vgen pharma plc evgen or the company or the group university of rochester collaboration. Evgen pharma plc stock technical analysis with dynamic. Evgen pharma plcnottingham university business school. Evgen pharma plc provides clinical stage drug development services. Evg, a clinical stage drug development company focused on the. The company is focused on the development of sulforaphanebased compounds.
He was formally the ceo of provexis plc a spinout from angle plc. Evgen pharma is a clinical stage drug development company developing sulforaphanebased medicines for the treatment of. Evgen pharma plc company profile and news bloomberg. L stock quote, history, news and other vital information to help you with your stock trading and investing.
Evg, a clinical stage drug development company focused on the treatment of cancer and. Barrons also provides information on historical stock ratings, target prices, company earnings, market valuation and. Evgens pipeline is based on our proprietary sulforadex technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and. Evg, the cheshirebased business which has made rapid progress since joining aim it now has two phase ii clinical trials underway, one in advanced breast cancer and one in a type of stroke known as a subarachnoid haemorrhage sah. Our pipeline is based on our proprietary sulforadex technology, and includes a number of.
Support resistance, pivot points for evgen pharma plc with key turning points and technical indicators. Gb00bsvyn304 view the latest price,charts and performance information at aj bell youinvest. Evgen pharma plc is a clinical stage drug development company that is engaged in the development of programs that focuses on breast cancer and subarachnoid haemorrhage. There are currently 2,646,263 shares in issue and the average daily traded volume is 334,532 shares. Oct 31, 2017 evgen pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evg, a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced an update on its two phase ii clinical trials.
Its core technology is sulforadex, which include synthetic and stabilized analogues of the naturally occurring compound sulforaphane. View recent trades and share price information for evgen pharma plc evg ordinary 0. Evgen pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions and the lead product is sulforadex. Evgen pharma plc filing history free information from. Evgen pharma plc shares jump after positive updates on two. About evgen pharma plc evgen pharma plc provides clinical stage drug development services. He was formally the ceo of provexis plc a spinout from angle plc, leading it from seed investment through to, and beyond, its admission to aim in 2005.
At the agm, the companys chairman, barry clare, will make the following statement. Evgen pharma esmo presentation of phase ii stem clinical. Our pipeline is derived from our proprietary sulforadex technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Evgen pharma plc evgen pharma or the company sas study clarification.
Dec 05, 2014 evgen pharma plc, a clinical stage drug development company focused on the treatment of cancer and neurological conditions, today announces its intention to join the aim market of the london stock exchange by way of a placing to raise up to. Evgen pharma plc free company information from companies house including registered office address, filing history, accounts, annual return, officers, charges, business activity. Evgen pharma plc placing of 18,918,919 ordinary shares of. Evgen pharma plc is a clinicalstage drug development company focused on cancer and neurological disease. Evgen pharma plc is a clinicalstage drug development company focused. Evgen pharma plc is a clinical stage drug development company, which engages in the development of pharmaceutical products and focus on cancer and neurological disease. Evg, a clinical stage drug development company focused on the treatment of cancer and neurological conditions, will hold its annual general meeting agm later today. Evgen pharma plc annual shareholders meeting jul 17, 2020. Evgen pharma plc intention to float on aim european. Evgen pharma is a clinical stage drug development company focused on cancer and neurological disease.
Evgen is a clinical stage drug development company focused on the treatment of cancer and. We are delighted to be collaborating again with evgen pharma. Evgen pharma plc evgen pharma or the company collaboration with kings college in ischaemic stroke evgen pharma aim. Find out the direct holders, institutional holders and mutual fund holders for evgen pharma plc ord 0. Evgen pharma company profile office locations, competitors. The company operates through the segment of development of pharmaceutical products all. L stock analyst estimates, including earnings and revenue, eps, upgrades and downgrades. Seattle, washington state in collaboration with the knight cancer institute. Its core technology is sulforadex, which include synthetic and stabilized.
Evgen pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions and the lead. Evgen pharma plc stock technical analysis with dynamic chart and delayed quote london stock exchange. Evgen pharma plc evgen pharma plc is a clinical stage drug development company, which engages in the development of pharmaceutical products and focus on cancer and neurological disease. Alliance news evgen pharma plc said wednesday it has entered its last patient in the doubleblind, placebocontrolled sas phase ii clinical trial that is testing its sfx01 product, aimed at a. Tests of the sfx01 drug candidate in patients who had suffered subarachnoid haemorrhage did not meet the clinical target. Northland capital today reaffirms its buy investment rating on evgen pharma plc lon. Evgen pharma evgen and the university of rochester school of medicine and dentistry have entered into a. Investegate evgen pharma plc announcements evgen pharma.
Professor giovanni mann, professor of vascular physiology at kings college london and supervisor for the project, commented. Evgen pharma markets its products in the united kingdom. Evg complete evgen pharma plc stock news by marketwatch. The software company said first half profit grew more than a third and added that it has bolstered its uk and european presence with two new acquisitions. May 04, 2016 evgen is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evg, a clinical stage drug development company focused on the treatment of cancer and neurological conditions, is pleased to announce a collaboration with kings college london kings to advance sfx01, the companys lead product candidate, towards the clinic as a. View realtime stock prices and stock quotes for a full financial overview. Evg, a clinical stage drug development company focused on the treatment of cancer and neurological conditions, is pleased to announce an update on its two phase ii clinical trials.
Uk stock price, news, historical charts, analyst ratings and financial information from wsj. London stock quote evgen pharma plc bloomberg markets. The company operates through the segment of development of. Evg, the clinical stage drug development company developing sulforaphane based medicines for the treatment of multiple diseases, announces that it has entered. Evgen pharma plc evgen or the company or the group university of rochester collaboration. Evgen pharma plc is a ukbased clinical stage drug development company. The companys core technology is sulforadex, a method for synthesizing and stabilizing the naturally occurring compound sulforaphane, which is a composition of synthetic. Evgen pharma plc share chat chat about evg shares evg.
213 995 199 328 200 1580 480 949 888 1264 929 1568 1517 734 138 1372 1446 287 895 1402 635 1070 399 455 1418 826 601 1372 394 1383 249 951 585 663 1322 1315